Business Context and Reporting Period
The submitted filing identifies Ambac Financial Group, Inc., not Octave Specialty Group Inc. It is an unaudited Form 10-Q for the quarter and nine months ended September 30, 2021. Ambac’s legacy financial guarantee businesses remain in runoff, while the company is developing specialty property and casualty program insurance through Everspan and managing general agency/underwriting operations through Xchange.
Financial Results and Position
| Metric | Three Months Ended September 30 | Nine Months Ended September 30 |
|---|---|---|
| Total revenues | $51 million, versus $62 million in 2020 | $229 million, versus $68 million in 2020 |
| Net income attributable to common stockholders | $17 million, versus a $108 million loss | $5 million, versus a $423 million loss |
| Diluted EPS | $0.35, versus $(2.33) | $(0.19), versus $(9.16) |
| Losses and loss expenses | $(55) million benefit, versus $83 million expense | $(73) million benefit, versus $216 million expense |
| Operating expenses | $32 million, versus $23 million | $94 million, versus $67 million |
| Interest expense | $44 million, versus $50 million | $144 million, versus $172 million |
| Net cash used in operating activities | Not separately provided | $136 million, versus $167 million |
Net investment income was $21 million in the third quarter and $112 million for the nine-month period, compared with $37 million and $69 million, respectively, in the prior-year periods. Nine-month results also included a $33 million gain from extinguishment of debt and a $19 million gain on derivative contracts, compared with a $61 million derivative loss in 2020.
- Total assets were $12.228 billion at September 30, 2021, down from $13.220 billion at December 31, 2020.
- Total liabilities were $11.088 billion, down from $12.074 billion.
- Total stockholders’ equity was $1.121 billion, compared with $1.140 billion at year-end 2020; Ambac Financial Group stockholders’ equity was $1.061 billion.
- Cash, cash equivalents and restricted cash totaled $22 million at September 30, 2021, compared with $50 million at September 30, 2020.
- Investments declined to $2.948 billion from $3.544 billion at December 31, 2020.
- Long-term debt declined to $2.215 billion from $2.739 billion, excluding $4.255 billion of consolidated variable-interest-entity debt.
- Adjusted book value, a non-GAAP measure, was $882 million, or $19.05 per share, versus $919 million, or $20.05 per share, at year-end 2020.
Material Changes Versus the Prior Comparable Period
- Loss experience improved materially, primarily due to favorable development in domestic public finance, particularly Puerto Rico, and structured finance, particularly RMBS.
- The insured portfolio was reduced through quota-share reinsurance, refinancings and commutations. Risk-reduction transactions totaled $2.667 billion for the nine months, reducing total net par outstanding 14% to $28.549 billion.
- Adversely classified credits declined 22% to $6.597 billion, and watch-list credits declined 17% to $3.931 billion.
- On July 6, 2021, Sitka issued $1.175 billion of senior secured notes due 2026. Proceeds funded part of the redemption of the $1.641 billion LSNI Ambac Note, with the remainder funded from other liquidity sources.
- AAC exchanged or retired junior surplus notes during the first quarter. The transactions reduced debt and generated a $33 million gain.
- Everspan received approximately $82 million of additional capital, launched its first specialty insurance program in May 2021 and held an A- A.M. Best financial strength rating. Everspan subsequently acquired Providence Washington Insurance Company on October 1, 2021.
- Operating expenses increased as Ambac expanded specialty insurance and MGA/U operations. Nine-month other income included $20 million of Xchange revenue.
Outlook, Risks, Contingencies and Unusual Items
The filing does not provide conventional earnings or revenue guidance. Management’s strategy is to continue the runoff and de-risking of AAC, pursue recoveries and liability-management transactions, rationalize capital and debt structures, and selectively grow specialty insurance and MGA/U businesses.
- Puerto Rico: Ambac had approximately $1.054 billion of net par exposure. The Eighth Amended Plan of Adjustment and related PRIFA and CCDA qualifying modifications remained subject to confirmation or approval, and recoveries depend significantly on uncertain contingent value instruments.
- Reserve sensitivity: Management estimated that adverse stress conditions could increase public-finance loss reserves by approximately $470 million, reducing stockholders’ equity from $1.121 billion to approximately $651 million.
- RMBS recoveries: The balance sheet included approximately $1.705 billion of net representation-and-warranty subrogation recoveries. If these recoveries were not realized, management indicated stockholders’ equity could decline to approximately negative $585 million.
- Debt and liquidity: Surplus-note principal and interest payments require approval from Wisconsin’s insurance regulator. OCI declined AAC’s request to pay the surplus notes in June 2021, and accrued unpaid surplus-note interest totaled $555 million at September 30, 2021.
- Regulatory capital: Ambac UK had a £10 million Solvency II capital deficiency at September 30, 2021, although the deficiency improved from £72 million at year-end 2020. Discussions with regulators remained ongoing.
- COVID-19 and credit risk: Economic recovery supported many exposures, but pandemic-related uncertainty, interest rates, defaults, forbearance, fiscal stress and market volatility could materially affect reserves and liquidity.
- Litigation: Ambac remains involved in Puerto Rico, RMBS, student-loan and other litigation. Outcomes and timing of recoveries are uncertain and may materially affect earnings, capital and cash flow.
- Unusual accounting items: Results were significantly affected by derivative fair-value changes, variable-interest-entity accounting, debt extinguishment gains, foreign exchange movements and non-GAAP adjustments.
Most Important Facts to Verify
- Confirm the company identity: the source filing is for Ambac Financial Group, Inc., while the request metadata names Octave Specialty Group Inc.
- Verify the status and final economics of the Puerto Rico plan of adjustment, PRIFA and CCDA qualifying modifications, and related contingent value instruments.
- Assess the collectability and litigation progress of the $1.705 billion net RMBS representation-and-warranty recovery asset.
- Review AAC’s statutory surplus, surplus-note payment restrictions, accrued interest and ability to service the Sitka, Tier 2 and surplus-note obligations.
- Evaluate Ambac UK’s regulatory capital deficiency and the feasibility of management’s remediation plans.
- Review the assumptions underlying loss reserves, including the disclosed $470 million public-finance stress sensitivity and potential losses exceeding stress estimates.
- Separate GAAP results from adjusted earnings and adjusted book value when comparing Ambac with other insurers.